loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 210115 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ASTELLAS (2)

filter

01 FOR SUSPENSION;ORAL (2)

filter

01 RX (2)

filter

01 PROGRAF (2)

filter

01 Yes (2)

URL Supplier Web Content
FOR SUSPENSION; OR...
EQ 0.2MG BASE/PACK...
2018-05-24
210115
PROGRAF
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
FOR SUSPENSION; OR...
EQ 1MG BASE/PACKET
2018-05-24
210115
PROGRAF
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 210115

Looking for FDA Orange Book APPLICATION 210115 2

19

Astellas Pharma, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is TACROLIMUS, with a corresponding application number 210115.

Regulatory Information RX

With a dosage strength EQ 0.2MG BASE/PACKET

Dosage Form Route FOR SUSPENSION; ORAL

Reference Listed Drug Yes

Approved since 2018-05-24

18

Astellas Pharma, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is TACROLIMUS, with a corresponding application number 210115.

Regulatory Information RX

With a dosage strength EQ 1MG BASE/PACKET

Dosage Form Route FOR SUSPENSION; ORAL

Reference Listed Drug Yes

Approved since 2018-05-24

Post Enquiry
POST ENQUIRY